{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T19:12:47Z","timestamp":1770837167295,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:00:00Z","timestamp":1768608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shanghai Anticancer Association EAGLET PROJECT","award":["SACA-CY21C04"],"award-info":[{"award-number":["SACA-CY21C04"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NSFC 82071878"],"award-info":[{"award-number":["NSFC 82071878"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Science and Technology Innovation Action Plan Medical Innovation Research Project","award":["21Y11910200"],"award-info":[{"award-number":["21Y11910200"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-026-02153-1","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T08:34:20Z","timestamp":1768638860000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MRI-Based peritumoral radiomics for predicting recurrence risk in ER+\/HER2- breast cancer"],"prefix":"10.1186","volume":"26","author":[{"given":"Yang","family":"Chen","sequence":"first","affiliation":[]},{"given":"Liang","family":"You","sequence":"additional","affiliation":[]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[]},{"given":"Lizhi","family":"Xie","sequence":"additional","affiliation":[]},{"given":"Qin","family":"Xiao","sequence":"additional","affiliation":[]},{"given":"Tianwen","family":"Xie","sequence":"additional","affiliation":[]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[]},{"given":"Qifeng","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Yingshi","family":"Sun","sequence":"additional","affiliation":[]},{"given":"Wei","family":"Tang","sequence":"additional","affiliation":[]},{"given":"Yajia","family":"Gu","sequence":"additional","affiliation":[]},{"given":"Weijun","family":"Peng","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2026,1,17]]},"reference":[{"issue":"3","key":"2153_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"14","key":"2153_CR2","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1200\/JCO.2005.05.2308","volume":"24","author":"F Kamangar","year":"2006","unstructured":"Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24(14):2137\u201350.","journal-title":"J Clin Oncol"},{"issue":"3","key":"2153_CR3","doi-asserted-by":"publisher","first-page":"412","DOI":"10.5306\/wjco.v5.i3.412","volume":"5","author":"O Yersal","year":"2014","unstructured":"Yersal O, Barutca S. Biological subtypes of breast cancer: prognostic and therapeutic implications. World J Clin Oncol. 2014;5(3):412\u201324.","journal-title":"World J Clin Oncol"},{"issue":"27","key":"2153_CR4","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1056\/NEJMoa041588","volume":"351","author":"S Paik","year":"2004","unstructured":"Paik S, Shak S, Tang G, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. New Engl J Med. 2004;351(27):2817\u201326.","journal-title":"New Engl J Med"},{"issue":"33","key":"2153_CR5","doi-asserted-by":"publisher","first-page":"5287","DOI":"10.1200\/JCO.2007.14.2364","volume":"25","author":"L Harris","year":"2007","unstructured":"Harris L, Fritsche H, Mennel R, et al. American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol. 2007;25(33):5287\u2013312.","journal-title":"J Clin Oncol"},{"key":"2153_CR6","doi-asserted-by":"publisher","first-page":"5909724","DOI":"10.1155\/2022\/5909724","volume":"2022","author":"FE de Jongh","year":"2022","unstructured":"de Jongh FE, Efe R, Herrmann KH, Spoorendonk JA. Cost and clinical benefits associated with oncotype DX(R) test in patients with Early-Stage HR+\/HER2- Node-Negative breast cancer in the Netherlands. Int J Breast Cancer. 2022;2022:5909724.","journal-title":"Int J Breast Cancer"},{"issue":"6","key":"2153_CR7","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.3390\/cancers15061840","volume":"15","author":"V Romeo","year":"2023","unstructured":"Romeo V, Cuocolo R, Sanduzzi L, et al. MRI radiomics and machine learning for the prediction of oncotype Dx recurrence score in invasive breast cancer. Cancers (Basel). 2023;15(6):1840.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"2153_CR8","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1148\/radiol.2019182947","volume":"292","author":"RM Mann","year":"2019","unstructured":"Mann RM, Cho N, Moy L, Breast MRI. State of the Art. Radiology. 2019;292(3):520\u201336.","journal-title":"Radiology"},{"issue":"7","key":"2153_CR9","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s00330-008-0863-7","volume":"18","author":"RM Mann","year":"2008","unstructured":"Mann RM, Kuhl CK, Kinkel K, Boetes C. Breast MRI: guidelines from the European society of breast imaging. Eur Radiol. 2008;18(7):1307\u201318.","journal-title":"Eur Radiol"},{"issue":"8","key":"2153_CR10","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.ejca.2010.02.015","volume":"46","author":"F Sardanelli","year":"2010","unstructured":"Sardanelli F, Boetes C, Borisch B, et al. Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer. 2010;46(8):1296\u2013316.","journal-title":"Eur J Cancer"},{"issue":"4","key":"2153_CR11","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1158\/2159-8290.CD-21-0090","volume":"11","author":"B Bhinder","year":"2021","unstructured":"Bhinder B, Gilvary C, Madhukar NS, Elemento O. Artificial intelligence in cancer research and precision medicine. Cancer Discov. 2021;11(4):900\u201315.","journal-title":"Cancer Discov"},{"issue":"2","key":"2153_CR12","first-page":"127","volume":"69","author":"WL Bi","year":"2019","unstructured":"Bi WL, Hosny A, Schabath MB, et al. Artificial intelligence in cancer imaging: clinical challenges and applications. CA Cancer J Clin. 2019;69(2):127\u201357.","journal-title":"CA Cancer J Clin"},{"key":"2153_CR13","doi-asserted-by":"publisher","first-page":"109996","DOI":"10.1016\/j.ejrad.2021.109996","volume":"144","author":"MG Davey","year":"2021","unstructured":"Davey MG, Davey MS, Boland MR, et al. Radiomic differentiation of breast cancer molecular subtypes using pre-operative breast imaging - A systematic review and meta-analysis. Eur J Radiol. 2021;144:109996.","journal-title":"Eur J Radiol"},{"key":"2153_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/cancers14194574","volume":"14","author":"D Santucci","year":"2022","unstructured":"Santucci D, Faiella E, Gravina M, et al. CNN-Based approaches with different tumor bounding options for lymph node status prediction in breast DCE-MRI. Cancers (Basel). 2022;14:19.","journal-title":"Cancers (Basel)"},{"issue":"6","key":"2153_CR15","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1002\/jmri.28219","volume":"56","author":"BC Musall","year":"2022","unstructured":"Musall BC, Adrada BE, Candelaria RP, et al. Quantitative apparent diffusion coefficients from peritumoral regions as early predictors of response to neoadjuvant systemic therapy in Triple-Negative breast cancer. J Magn Reson Imaging. 2022;56(6):1901\u20139.","journal-title":"J Magn Reson Imaging"},{"issue":"2","key":"2153_CR16","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1148\/radiol.211509","volume":"304","author":"BR Kwon","year":"2022","unstructured":"Kwon BR, Shin SU, Kim SY, et al. Microcalcifications and peritumoral edema predict survival outcome in luminal breast cancer treated with neoadjuvant chemotherapy. Radiology. 2022;304(2):310\u20139.","journal-title":"Radiology"},{"issue":"4","key":"2153_CR17","doi-asserted-by":"publisher","first-page":"e192561","DOI":"10.1001\/jamanetworkopen.2019.2561","volume":"2","author":"N Braman","year":"2019","unstructured":"Braman N, Prasanna P, Whitney J, et al. Association of peritumoral radiomics with tumor biology and pathologic response to preoperative targeted therapy for HER2 (ERBB2)-Positive breast cancer. JAMA Netw Open. 2019;2(4):e192561.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"2153_CR18","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1148\/radiol.2021210738","volume":"302","author":"M Fan","year":"2022","unstructured":"Fan M, Cui Y, You C, et al. Radiogenomic signatures of oncotype DX recurrence score enable prediction of survival in Estrogen Receptor-Positive breast cancer: A multicohort study. Radiology. 2022;302(3):516\u201324.","journal-title":"Radiology"},{"issue":"1","key":"2153_CR19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s00330-019-06383-6","volume":"30","author":"JY Kim","year":"2020","unstructured":"Kim JY, Kim JJ, Hwangbo L, et al. Diffusion-weighted MRI of Estrogen receptor-positive, HER2-negative, node-negative breast cancer: association between intratumoral heterogeneity and recurrence risk. Eur Radiol. 2020;30(1):66\u201376.","journal-title":"Eur Radiol"},{"issue":"10","key":"2153_CR20","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.3390\/cancers12102772","volume":"12","author":"MA Jacobs","year":"2020","unstructured":"Jacobs MA, Umbricht CB, Parekh VS, et al. Integrated multiparametric radiomics and informatics system for characterizing breast tumor characteristics with the oncotypedx gene assay. Cancers (Basel). 2020;12(10):2772.","journal-title":"Cancers (Basel)"},{"key":"2153_CR21","doi-asserted-by":"crossref","unstructured":"Chiacchiaretta P, Mastrodicasa D, Chiarelli AM et al. MRI-Based radiomics approach predicts tumor recurrence in ER + \/HER2 - Early breast cancer patients. J Digit Imaging. 2023;36(3):1071-1080.","DOI":"10.1007\/s10278-023-00781-5"},{"key":"2153_CR22","volume-title":"ACR BI-RADS\u00ae magnetic resonance imaging. ACR BI-RADS\u00ae atlas, breast imaging reporting and data system","author":"EA Morris","year":"2013","unstructured":"Morris EA, Comstock CE, Lee CH, et al. ACR BI-RADS\u00ae magnetic resonance imaging. ACR BI-RADS\u00ae atlas, breast imaging reporting and data system. Reston, VA: American College of Radiology; 2013."},{"issue":"1","key":"2153_CR23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/jmri.26224","volume":"49","author":"C Liu","year":"2019","unstructured":"Liu C, Ding J, Spuhler K, et al. Preoperative prediction of Sentinel lymph node metastasis in breast cancer by radiomic signatures from dynamic contrast-enhanced MRI. J Magn Reson Imaging. 2019;49(1):131\u201340.","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"2153_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13058-017-0846-1","volume":"19","author":"NM Braman","year":"2017","unstructured":"Braman NM, Etesami M, Prasanna P, et al. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI. Breast Cancer Res. 2017;19(1):57.","journal-title":"Breast Cancer Res"},{"key":"2153_CR25","doi-asserted-by":"publisher","first-page":"773581","DOI":"10.3389\/fimmu.2021.773581","volume":"12","author":"X Han","year":"2021","unstructured":"Han X, Cao W, Wu L, Liang C. Radiomics assessment of the tumor immune microenvironment to predict outcomes in breast cancer. Front Immunol. 2021;12:773581.","journal-title":"Front Immunol"},{"issue":"10","key":"2153_CR26","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1002\/1097-0142(19951115)76:10<1772::AID-CNCR2820761014>3.0.CO;2-O","volume":"76","author":"R Lauria","year":"1995","unstructured":"Lauria R, Perrone F, Carlomagno C, et al. The prognostic value of lymphatic and blood vessel invasion in operable breast cancer. Cancer. 1995;76(10):1772\u20138.","journal-title":"Cancer"},{"key":"2153_CR27","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/1471-2407-9-109","volume":"9","author":"AV Britto","year":"2009","unstructured":"Britto AV, Schenka AA, Moraes-Schenka NG, et al. Immunostaining with D2-40 improves evaluation of lymphovascular invasion, but May not predict Sentinel lymph node status in early breast cancer. BMC Cancer. 2009;9:109.","journal-title":"BMC Cancer"},{"issue":"17","key":"2153_CR28","doi-asserted-by":"publisher","first-page":"e71172","DOI":"10.1002\/cam4.71172","volume":"14","author":"Y Chen","year":"2025","unstructured":"Chen Y, Xie L, Tang W, et al. MRI radiomics signatures of 21-Gene recurrence score for predicting survival in ER+\/HER2- breast cancer. Cancer Med. 2025;14(17):e71172.","journal-title":"Cancer Med"},{"issue":"2","key":"2153_CR29","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1148\/radiol.2016152331","volume":"281","author":"MS Bae","year":"2016","unstructured":"Bae MS, Shin SU, Ryu HS, et al. Pretreatment MR imaging features of Triple-Negative breast cancer: association with response to neoadjuvant chemotherapy and Recurrence-Free survival. Radiology. 2016;281(2):392\u2013400.","journal-title":"Radiology"},{"issue":"3","key":"2153_CR30","first-page":"233","volume":"16","author":"PA Baltzer","year":"2010","unstructured":"Baltzer PA, Yang F, Dietzel M, et al. Sensitivity and specificity of unilateral edema on T2w-TSE sequences in MR-Mammography considering 974 histologically verified lesions. Breast J. 2010;16(3):233\u20139.","journal-title":"#N\/A"},{"issue":"1","key":"2153_CR31","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1148\/radiol.2017171157","volume":"287","author":"H Cheon","year":"2018","unstructured":"Cheon H, Kim HJ, Kim TH, et al. Invasive breast cancer: prognostic value of peritumoral edema identified at preoperative MR imaging. Radiology. 2018;287(1):68\u201375.","journal-title":"Radiology"},{"issue":"1","key":"2153_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1148\/radiol.2021202604","volume":"299","author":"TL Harada","year":"2021","unstructured":"Harada TL, Uematsu T, Nakashima K, et al. Evaluation of breast edema findings at T2-weighted breast MRI is useful for diagnosing occult inflammatory breast cancer and can predict prognosis after neoadjuvant chemotherapy. Radiology. 2021;299(1):53\u201362.","journal-title":"Radiology"},{"key":"2153_CR33","doi-asserted-by":"crossref","unstructured":"Jiang T, Song J, Wang X et al. Intratumoral and peritumoral analysis of Mammography, tomosynthesis, and multiparametric MRI for predicting Ki-67 level in breast cancer: a radiomics-based study. Mol Imag Biol. 2022;24(4):550-9.","DOI":"10.1007\/s11307-021-01695-w"},{"issue":"1","key":"2153_CR34","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/jmri.28273","volume":"57","author":"M Caballo","year":"2023","unstructured":"Caballo M, Sanderink WBG, Han L, et al. Four-Dimensional machine learning radiomics for the pretreatment assessment of breast cancer pathologic complete response to neoadjuvant chemotherapy in dynamic Contrast-Enhanced MRI. J Magn Reson Imaging. 2023;57(1):97\u2013110.","journal-title":"J Magn Reson Imaging"},{"issue":"2","key":"2153_CR35","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/jmri.28776","volume":"59","author":"W Jiang","year":"2024","unstructured":"Jiang W, Meng R, Cheng Y, et al. Intra- and peritumoral based radiomics for assessment of lymphovascular invasion in invasive breast cancer. J Magn Reson Imaging. 2024;59(2):613\u201325.","journal-title":"J Magn Reson Imaging"},{"issue":"12","key":"2153_CR36","doi-asserted-by":"publisher","first-page":"7685","DOI":"10.1245\/s10434-022-12034-w","volume":"29","author":"C Li","year":"2022","unstructured":"Li C, Lu N, He Z, et al. A noninvasive tool based on magnetic resonance imaging radiomics for the preoperative prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer. Ann Surg Oncol. 2022;29(12):7685\u201393.","journal-title":"Ann Surg Oncol"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-026-02153-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02153-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02153-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T18:22:57Z","timestamp":1770834177000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12880-026-02153-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,17]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2153"],"URL":"https:\/\/doi.org\/10.1186\/s12880-026-02153-1","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,17]]},"assertion":[{"value":"7 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study complied with the Declaration of Helsinki. This study was approved by the Ethics Committee of Fudan University Shanghai Cancer Center (2203252-23), and informed consent was waived owing to the retrospective nature of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}